Aiguo Li

Aiguo Li


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2021 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
WMWei Mao
Wei Mao
FDFei Dong
Fei Dong
GHGuowei Huang
Guowei Huang
PHPeiliang He
Peiliang He
HCHuan Chen
Huan Chen
ALAiguo Li
Aiguo Li
Background: Osteoporotic vertebral compression fracture (OVCF) is one of the most common fragile fractures, and percutaneous vertebroplasty provides considerable long-term benefits. At the same time, there are many reports of postoperative complications, among which fracture after percutaneous vertebroplasty is one of the complications after vertebroplasty (PVP). Although there are many reports on the risk factors of secondary fracture after PVP at home and abroad, there is no systematic analysis on the related factors of secondary fracture after PVP. Methods: The databases, such as CNKI, Wan Fang Database and PubMed, were searched for documents on secondary fractures after percutaneous vertebroplasty published at home and abroad from January 2011 to March 2021. After strictly evaluating the quality of the included studies and extracting data, a meta-analysis was conducted by using Revman 5.3 software. Results: A total of 9 articles were included, involving a total of 1882 patients, 340 of them diagnosed as secondary fractures after percutaneous vertebroplasty. Conclusion: The additional history of fracture, age, bone mineral density (BMD), bone cement leakage, intravertebral fracture clefts and Cobb Angle might be risk factors related to secondary fractures after percutaneous vertebroplasty for osteoporotic vertebral compression fractures. The height of vertebral anterior and body mass index (BMI) were not correlated.

6 April 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
JZJinli Zhang
Jinli Zhang
ZLZhihe Liu
Zhihe Liu
YLYang Luo
Yang Luo
XLXiaojian Li
Xiaojian Li
GHGuowei Huang
Guowei Huang
SQShengnan Qin
Shengnan Qin
Mesenchymal stem cells (MSCs) play an important role in developing bone tissue engineered constructs due to their osteogenic and chondrogenic differentiation potential. MSC-based tissue engineered constructs are generally considered a safe procedure, however, the long-term results obtained up to now are far from satisfactory. The main causes of these therapeutic limitations are inefficient homing, engraftment, and directional differentiation. Flavonoids are a secondary metabolite, widely existed in nature and have many biological activities. For a long time, researchers have confirmed the anti-osteoporosis effect of flavonoids through in vitro cell experiments, animal studies. In recent years the regulatory effects of flavonoids on mesenchymal stem cells (MSCs) differentiation have been received increasingly attention. Recent studies revealed flavonoids possess the ability to modulate self-renewal and differentiation potential of MSCs. In order to facilitate further research on MSCs osteogenic differentiation of flavonoids, we surveyed the literature published on the use of flavonoids in osteogenic differentiation of MSCs, and summarized their pharmacological activities as well as the underlying mechanisms, aimed to explore their promising therapeutic application in bone disorders and bone tissue engineered constructs.

29 October 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
WMWei Mao
Wei Mao
GHGuowei Huang
Guowei Huang
HCHuan Chen
Huan Chen
XLXU Liangliang
XU Liangliang
SQShengnan Qin
Shengnan Qin
ALAiguo Li
Aiguo Li
Bone regeneration in osteoporosis and fragility fractures which are highly associated with age remains a great challenge in the orthopedic field, even though the bone is subjected to a continuous process of remodeling which persists throughout lifelong. Regulation of osteoblast and osteoclast differentiation is recognized as effective therapeutic targets to accelerate bone regeneration in osteopenic conditions. Anthocyanins (ACNs), a class of naturally occurring compounds obtained from colored plants, have received increasing attention recently because of their well-documented biological effects, such as antioxidant, anti-inflammation, and anti-apoptosis in chronic diseases, like osteoporosis. Here, we summarized the detailed research progress on ACNs on bone regeneration and their molecular mechanisms on promoting osteoblast differentiation as well as inhibiting osteoclast formation and differentiation to explore their promising therapeutic application in repressing bone loss and helping fragility fracture healing. Better understanding the role and mechanisms of ACNs on bone regeneration is helpful for the prevention or treatment of osteoporosis and also for the exploration of new bone regenerative medicine.

14 January 2023 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
PDF file
PHPeiliang He
Peiliang He
ZLZiting Liu
Ziting Liu
HCHuan Chen
Huan Chen
GHGuowei Huang
Guowei Huang
WMWei Mao
Wei Mao
ALAiguo Li
Aiguo Li
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.

1 January 2021
Verified
Journal Article
Closed access
PWPengzhen Wang
Pengzhen Wang
JLJian Liu
Jian Liu
SZShaoheng Zhang
Shaoheng Zhang
PZPingping Zhu
Pingping Zhu
XXXifeng Xiong
Xifeng Xiong
ZLZhihe Liu
Zhihe Liu

28 May 2025 in Journal of Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
YJYingjuan Jiang
Yingjuan Jiang
GLGeng Liu
Geng Liu
QLQingqing Liu
Qingqing Liu
LZLanyue Zhang
Lanyue Zhang
YTYanping Tan
Yanping Tan
ALAiguo Li
Aiguo Li
Yingjuan Jiang, Geng Liu, Qingqing Liu, Lanyue Zhang, Yanping Tan, Junlin Cen, Yan Zhao, and Aiguo Li. J. Microbiol. Biotechnol. 2025;35:1-11. https://doi.org/10.4014/jmb.2411.11053